|
December 23, 2005 Categories: Uncategorized Posted by admin
MIV Therapeutics, Inc. (OTCBB:MIVT) (FWB:MIV), a leading developer of new-generation biocompatible coatings and advanced drug delivery systems, has announced that the Company was the subject of an article in a recent issue of “Der Aktionar,” an investment and finance periodical published in Germany, which praised the medical and marketplace potential of the Company’s innovative drug-eluting stent technologies as well as its novel stroke-preventing devices.
Full news
|
|
